Company / Current Liabilities
ARS Pharmaceuticals, Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$39.1M
FY2025
5-year range
$2.4M / $39.1M
FY2021-FY2025
Trend
+67.0%
vs FY2024
Sector context
#160 of 213
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s current liabilities of $39M is lower than 75% of companies in the Health Care sector (FY2025). Increased from $2M to $39M over the past 2 years.
Based on SEC 10-K filings.
$39M in FY2025 with a 5-year CAGR of +32.5%.
Increased from $2M to $39M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +93.0%
- 5-Year CAGR
- +32.5%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 213This company $39.1M Sector average $1.6B
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +32.5%, indicating consistent growth.
- In FY2025, current liabilities increased 67.0% year-over-year.
- Ranks #160 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.1M | +67.0% |
| FY2024 | $23.4M | +880.3% |
| FY2023 | $2.4M | -56.1% |
| FY2022 | $5.4M | -33.5% |
| FY2021 | $8.2M | -14.7% |
| FY2020 | $9.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026